SK Chemical attracted R&D funds from the Bill & Melinda Gates Foundation for vaccine studies

Published: 2014-12-23 14:49:31

Updated: 2014-12-23 14:49:31

In order to conduct clinical research and development fora newly co-developingtyphoid vaccine, SK Chemical and the International Vaccine Institute (IVI) announced that they were supported with $ 4.9 million (KRW 5.9 billion) funds from the Bill & Melinda Gates Foundation.

The funds will be administered from this December to September 2017 and are expected to use in initial clinical studi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.